Practitioner Perspectives: 2019 Network-Wide Meeting Interview Series – Côte d’Ivoire Interview on What They Hope to Learn from LNCT

Kanopi

During our network-wide meeting, which took place in Tangerang, Indonesia in July 2019, we sat down with a few participants to hear about their experiences related to topics around their Gavi transition experiences. This interview features the following LNCT members:

  • Interviewer: Alexis Mourou Moyoka, Head Doctor of the EPI, Congo
  • Interviewees: Mamadou Samba, Director General of Health of the Ministry of Health and Public Hygiene, Côte d’Ivoire
    Kouadio Daniel Ekra, Coordinating Director of the Expanded Program of Immunization, Côte d’Ivoire

*You can view the interview transcript in English here.

You May Also Like

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Read More

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more … Read More

Center for Global Development – Global Immunization and Gavi: Five Priorities for the Next Five Years

Below is an excerpt from the Center for Global Development’s overview note.  Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come … Read More